$ECL

Ecolab Releases Q2 2026 Financial Results

Ecolab reported Q2 2026 adjusted EPS of $2.09, matching the $2.10 estimate, on revenue of $4.42B, up 10% from Q2 2025. Adjusted net income was $589.6M. Global Water revenue rose to $2.22B (+10%). FY 2026 adjusted EPS guidance is $8.05 to $8.25.

Original reporting
Published Jul 28, 2026, 5:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 6:57 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ecolab Releases Q2 2026 Financial Results — source image
Decision brief

The 30-second read

$ECLBullishMed
01

Why it matters

Investors can update earnings models using the reported Q2 adjusted EPS and revenue, then stress-test the FY 2026 adjusted EPS range against organic sales growth and segment performance.

02

Market read

The combination of an in-line quarterly print and a specific full-year EPS range is actionable for traders managing earnings revisions and forward expectations.

03

What to watch

The article does not provide segment margin, cash flow, or detailed acquisition/currency impacts, which are often key for earnings-quality and forward estimates.

Relevance 8/10Novelty 7/10Timing: after-hours/late-day following Q2 2026 results release

Background

Ecolab is an industrial water and hygiene solutions provider, reporting Q2 2026 results and issuing FY 2026 adjusted EPS guidance.

Company-level read

Ticker impact

$ECLBullishMedium confidence
Context

Ecolab reported Q2 2026 adjusted EPS of $2.09 and revenue of $4.42B, plus FY 2026 adjusted EPS guidance of $8.05 to $8.25.

Expected impact

Likely supportive near-term bias if the market treats the results as in-line and the guidance range as credible, with upside/downside driven by how investors interpret organic growth and margin trajectory.

Evidence & confidence

The article includes both quarterly results versus consensus and a specific FY 2026 adjusted EPS outlook, which are primary drivers for earnings revisions and near-term sentiment.

Market effects

Reinforces demand visibility in industrial water and hygiene, which can modestly influence sentiment across water-treatment and facility-services peers.

Limited explicit regional detail, but global segment growth supports a broadly diversified demand narrative.

Sustained sustainability-driven capex and food safety spending is consistent with broader global industrial services demand.

Counterpoint

In-line EPS and only modest organic growth may limit upside, with the stock reaction depending on whether margins or backlog trends are stronger than implied.

Key entities

  • Ecolab Inc.

    Reported Q2 2026 adjusted EPS of $2.09 on $4.42B revenue and guided FY 2026 adjusted EPS to $8.05 to $8.25.

Related articles

$ECLMed

Ecolab bets $7bn to tackle AI's growing water problem

Ecolab said it has spent $7 billion in the past six months to address water use from AI data centers, citing water as a key constraint. The company’s main move was a $4.75 billion acquisition of Calgary-based CoolIT Systems, which uses closed-loop liquid cooling to capture chip heat without misting or evaporating water. Ecolab reported $16 billion in annual revenue and targets 2030 sustainability goals.

$ECLMed

Ecolab Inc. Q2 2026 Earnings Call Summary

Ecolab reported Q2 2026 earnings call updates, citing value-based pricing and energy surcharges offsetting rising commodity costs. Global High-Tech growth accelerated after the CoolIT acquisition, and Life Sciences grew 15%. Management raised the 2030 High-Tech sales target to $4B and guided H2 organic sales growth of 6% to 7% with adjusted operating margin of 19%.

$ECLMedAI 8/10

Ecolab Inc (ECL) Q2 2026 Earnings Call Transcript

Ecolab (NYSE: ECL) held its Q2 2026 earnings call. The company reported adjusted EPS up 11%, driven by 5% organic sales growth, stable organic gross margin, and productivity. It said pricing strengthened to 4% in Q2, targeting 5% to 6% in the second half, while volumes rose 1%. Ecolab also cited Life Sciences growth (15%) and Global High-Tech growth (29%) after the July 2 acquisition of Coolite Systems.